Skip to content

Heamodynamic Effects of Paracetamol in Septic Shock Patients

Haemodynamic Effects of Paracetamol (Acetaminophen) as Extended Intravenous Infusion Versus Intravenous Bolus in Septic Shock Patients

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06076980
Enrollment
61
Registered
2023-10-11
Start date
2020-11-01
Completion date
2023-01-24
Last updated
2023-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis, Septic Shock

Keywords

acetaminophen, paracetamol, septic shock, hemodynamic effects, blood pressure, icu

Brief summary

Sepsis is life-threatening organ dysfunction caused by a dysregulated host response to infection. Septic shock is defined as sepsis that has circulatory, cellular, and metabolic abnormalities that are associated with a greater risk of mortality than sepsis alone. Clinically, this includes patients who fulfill the criteria for sepsis who, despite adequate fluid resuscitation, require vasopressors to maintain a mean arterial pressure ≥65 mmHg and have a lactate \>2 mmol/L (\>18 mg/dL). Feve is a common sign of infection in septic shock critically ill patients. Many critically ill patients experience pain. Paracetamol is considered safe and currently one of the most common antipyretics and used as part of multimodal analgesia for acute pain in the intensive care unit. According to the company's product information leaflet, the rate of hypotension complicating intravenous paracetamol treatment ranges from 0.01 to 0.1%. However, recent studies reported a much higher incidence and may be harmful in critically ill adults. The hemodynamic effects of intravenous (IV) paracetamol are unknown in septic shock patients, that the most vulnerable population and hemodynamically unstable. The aim of this study is to assess the incidence of hypotension of the extended intravenous paracetamol (acetaminophen) infusion over three hours in comparing with intravenous paracetamol bolus over 15 minutes in hemodynamically unstable patients (septic shock).

Detailed description

Sepsis, inflammatory response to infection, contributes directly or indirectly to mortality in the majority of critically ill patients. An elevated cardiac index and a decreased systemic vascular resistance leading to hypotension and hypoperfusion of vital organs characterize the early stage of septic shock. The hypotensive state is often not amenable to fluid resuscitation alone and requires institution of vasoactive agents to counter the profound fall in systemic vascular resistance, which is an integral feature of septic shock . Acetaminophen is the antipyretic and analgesic that is most often given to hospitalized patients, including those in critical care units. The mechanism of action of acetaminophen remains incompletely understood, but the antipyretic response appears to be due to blocking cyclooxygenase-II and inhibiting prostaglandin-II synthesis in the central nervous system. Intravenous (IV) acetaminophen has gained popularity for inpatient management of acute pain for its practical and clinical advantages. IV administration is associated with more predictable pharmacokinetic performance compared with rectal (30%-40% bioavailability) and oral dosage forms of acetaminophen (60%-70% bioavailability). Predictable kinetics as well as ease of IV administration has made it an especially attractive option in the critically ill patients who have altered gut absorption secondary to numerous pathophysiological and therapeutic influences . IV acetaminophen has shown promise in improving patient satisfaction, managing fever, and decreasing postoperative opioid requirements. These features have made it one of the most widely ordered medications within critical care and surgical services. Product information for IV acetaminophen lists mild effects such as nausea or vomiting among the most common adverse events (incidence ≥ 5%), with the estimated incidence of more serious adverse effects such as hypotension being \<1%. However, there have been an increasing number of randomized controlled trials which indicated that the incidence of IV acetaminophen-induced hypotension may be higher than previously reported by manufacturers. These publications have prompted investigators to look more closely at the possible untoward effects of IV acetaminophen across a variety of populations. . None of these studies examined whether the extended infusion of IV paracetamol can minimize the degree of hypotension in critically heamodynamic unstable patients.

Interventions

DRUGParacetamol

compare the hemodynamic parameters of paracetamol as bolus versus extended infusion

DRUGNormal saline

as placebo

Sponsors

Ayah Mohammed Khalil
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age adult ≥ 18 years old. 2. The patient fulfills the criteria of septic shock definition: * Sepsis needs vasopressor therapy. * Serum lactate level greater than 2 mmol/l (SSC 2016). 3. Patient with contractility greater than 40%

Exclusion criteria

1. paracetamol hypersensitivity or allergy. 2. Acute liver injury or failure 3. Childs-Pugh C liver disease 4. Heat stroke. 5. Malignant hyperthermia. 6. Neuroleptic Malignant Syndrome. 7. Continous renal replacement therapy. 8. Ventricular assist device. 9. Around-the-clock scheduled of acetaminophen-containing medications administration or non-steroidal anti-inflammatory drugs. 10. Pregnancy/lactation.

Design outcomes

Primary

MeasureTime frameDescription
The incidence of hypotension .pre intervention and six hours after the intervantiondefined as a decrease in SBP ≥ 20٪ from baseline, by extended infusion of intravenous paracetamol

Secondary

MeasureTime frameDescription
The changes in hemodynamic parameterspre intervention and six hours after the intervantionChanges in mean arterial pressure(mmHg), diastolic blood pressure (mmHg)
The changes in temperaturepre intervention and six hours after the intervantionChanges in temperature (celsius)
The changes in vassopresors and fluid boluspre intervention and six hours after the intervantionchanges in vassopresors infusion rate (mcg/ min) and fluid bolus

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026